Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / GENOMIC BIOTECH
-
Total 13F shares
-
4,466,420
-
Share change
-
-916,292
-
Total reported value
-
$67,117,984
-
Price per share
-
$15.03
-
Number of holders
-
56
-
Value change
-
-$15,572,776
-
Number of buys
-
31
-
Number of sells
-
30
Institutional Holders of GLOBAL X FDS - GENOMIC BIOTECH (GNOM) as of Q1 2022
As of 31 Mar 2022,
GLOBAL X FDS - GENOMIC BIOTECH (GNOM) was held by
56 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,466,420 shares.
The largest 10 holders included
Private Advisor Group, LLC, PNC Financial Services Group, Inc., Mirae Asset Global Investments Co., Ltd., McGuire Investment Group, LLC, UBS Group AG, One Capital Management, LLC, MML INVESTORS SERVICES, LLC, LPL Financial LLC, HighTower Advisors, LLC, and Elmwood Wealth Management, Inc..
This page lists
58
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.